Dr. P says he's trying to get funding from DARPA to study this. A few general notes about inhaled nitric oxide: first, in a clinical setting, it's used primarily to dilate pulmonary vessels. It is rapidly scavenged by hemoglobin, which delivers it to areas of local tissue hypoxia, so it doesn't really have systemic effects. Also, it binds with the superoxide anion to produce peroxynitrite, which can be further changed to peroxynitrous acid (chemical formula ONOOH), which if present in sufficient quantities can damage the lung's surfactant. The dosing isn't entirely clear, either.
So, Dr. P's short answer is "not ready for prime time", but we may see something coming out in the next couple of years. Thanks for starting this discussion!
Best regards,
DDM
So, Dr. P's short answer is "not ready for prime time", but we may see something coming out in the next couple of years. Thanks for starting this discussion!
Best regards,
DDM